glp-1 covered by blue cross blue shield to stop covering popular weight-loss drugs Most Americans do not use

Clean, user-friendly interface

Tools & support while taking GLP-1 medications

The Trump administration also announced in April 2025 that it does not intend to approve new or extend existing requests for federal matching funds for state expenditures for DSHP

In the absence of safety data, most clinicians advise that pregnant or breastfeeding individuals avoid this compounded preparation unless the anticipated benefit clearly outweighs theoretical fetal or neonatal risks

With the majority of people expressing interest in the new obesity treatment not being previous users of weight-loss injections, this indicated that the new pill could widen access to millions of people across the country

Our experienced team works with you to achieve a common goal: helping you feel healthy and beautiful